A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BLI / biolayer interferometry

[Related PubMed/MEDLINE]
Total Number of Papers: 81
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BLI  (>> Co-occurring Abbreviation)
Long Form:   biolayer interferometry
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Allergenicity assessment on thermally processed peanut influenced by extraction and assessment methods. DPP, ELISA
2019 Flow-Induced Dispersion Analysis (FIDA) for Protein Quantification and Characterization. ELISA, FIDA, SPR, TDA
2019 Hydrogen-Deuterium Exchange Epitope Mapping Reveals Distinct Neutralizing Mechanisms for Two Monoclonal Antibodies against Diphtheria Toxin. DT, DTx, HB-EGF, HDX-MS, mAbs
2019 Oxazole-benzenesulfonamide derivatives inhibit HIV-1 reverse transcriptase interaction with cellular eEF1A and reduce viral replication. RT, WT
2019 Rapid and Sensitive Detection of the Interaction of Human Papillomavirus Virus-Like Particles with Yeast Whole Cell RNA Using Biolayer Interferometry. HPV, VLPs
2019 The C-terminal SAM domain of p73 binds to the N terminus of MDM2. CD, SAM, TA
2019 Therapeutic potential of nimotuzumab PEGylated-maytansine antibody drug conjugates against EGFR positive xenograft. ADCs, DAR, EGFR, MBP, NIR
2018 89Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I. 89Zr-DFO-nimotuzumab, EGFR
2018 A novel SigB(Q225P) mutation in Staphylococcus aureus retains virulence but promotes biofilm formation. EMSA, RT-qPCR, SigB
10  2018 Analyzing Dynamic Protein Complexes Assembled On and Released From Biolayer Interferometry Biosensor Using Mass Spectrometry and Electron Microscopy. CMG2, PA
11  2018 Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus. HA, mAb, NA
12  2018 Capturing the Interaction Kinetics of an Ion Channel Protein with Small Molecules by the Bio-layer Interferometry Assay. hEAG1
13  2018 Comparison of different immunoassay methods to detect human anti-drug antibody using the WHO erythropoietin antibody reference panel for analytes. ADA, ECL, EPO, SPR, WHO
14  2018 Copper mediated amyloid-beta binding to Transthyretin. AD, TTR
15  2018 Deciphering critical amino acid residues to modify and enhance the binding affinity of ankyrin scaffold specific to capsid protein of human immunodeficiency virus type 1. CA, HIV-1, vdW
16  2018 Interaction between parasite-encoded JAB1/CSN5 and macrophage migration inhibitory factor proteins attenuates its proinflammatory function. EhJAB1, EhMIF
17  2018 MgATP hydrolysis destabilizes the interaction between subunit H and yeast V1-ATPase, highlighting H's role in V-ATPase regulation by reversible disassembly. EG, HNT, ITC
18  2018 Murine leukemia virus p12 tethers the capsid-containing pre-integration complex to chromatin by binding directly to host nucleosomes in mitosis. CA, CBSs, CTD, MLV, PIC
19  2018 Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays. HA, mAb, SRID
20  2018 Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Plasmodium falciparum Circumsporozoite Protein Antigens. CSP
21  2018 Rapid and sensitive detection of nodularin-R in water by a label-free BLI aptasensor. NOD-R
22  2018 Sequencing and Affinity Determination of Antigen-Specific B Lymphocytes from Peripheral Blood. BCR, IMAC, PBMCs
23  2018 Single-chain antibody against Reg4 suppresses gastric cancer cell growth and enhances 5-FU-induced cell death in vitro. 5-FU, CDRs, Reg4
24  2018 Streamlined circular proximity ligation assay provides high stringency and compatibility with low-affinity antibodies. c-PLA, PLA, SPR
25  2018 The Chaperonin GroEL: A Versatile Tool for Applied Biotechnology Platforms. EM, vWF
26  2017 A Comprehensive Study of the Interaction between Peptidoglycan Fragments and the Extracellular Domain of Mycobacterium tuberculosis Ser/Thr Kinase PknB. nMS, PGN, STD
27  2017 A novel label-free cell-based assay technology using biolayer interferometry. cBLI, DMR, EGFR
28  2017 An approach for liposome immobilization using sterically stabilized micelles (SSMs) as a precursor for bio-layer interferometry-based interaction studies. SSMs
29  2017 Biolayer interferometry of lipid nanodisc-reconstituted yeast vacuolar H+ -ATPase. MSP, V-ATPase
30  2017 Biolayer interferometry predicts ELISA performance of monoclonal antibody pairs for Plasmodium falciparum histidine-rich protein 2. ELISAs, HRP2, LFAs
31  2017 Biomolecular Interaction Assays Identified Dual Inhibitors of Glutaminase and Glutamate Dehydrogenase That Disrupt Mitochondrial Function and Prevent Growth of Cancer Cells. GDH, GO, HRP
32  2017 Designing binding kinetic assay on the bio-layer interferometry (BLI) biosensor to characterize antibody-antigen interactions. mAbs, MTL, SPR, SPRi
33  2017 Destruxin A Induces and Binds HSPs in Bombyx mori Bm12 Cells. DA, DARTS, qPCR
34  2017 Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms. CFM, mAbs, PCSK9, SPR
35  2017 Enzyme-linked, aptamer-based, competitive biolayer interferometry biosensor for palytoxin. ---
36  2017 Origins of the enhanced affinity of RNA-protein interactions triggered by RNA phosphorodithioate backbone modification. ---
37  2017 Preparation of glycoconjugates from unprotected carbohydrates for protein-binding studies. MST, OEG-linker, SPR
38  2017 Rapid Biolayer Interferometry Measurements of Urinary CXCL9 to Detect Cellular Infiltrates Noninvasively After Kidney Transplantation. ACR, ELISA
39  2017 Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development. ---
40  2017 Universal label-free in-process quantification of influenza virus-like particles. VLPs
41  2016 A biolayer interferometry-based assay for rapid and highly sensitive detection of biowarfare agents. ---
42  2016 A method for measuring binding constants using unpurified in vivo biotinylated ligands. ---
43  2016 A method to determine the mode of binding for GCPII inhibitors using bio-layer interferometry. GCPII
44  2016 Chaperonin-Based Biolayer Interferometry To Assess the Kinetic Stability of Metastable, Aggregation-Prone Proteins. ---
45  2016 Comparison of Enzyme-Linked Immunosorbent Assay, Surface Plasmon Resonance and Biolayer Interferometry for Screening of Deoxynivalenol in Wheat and Wheat Dust. DON, ELISA, SPR
46  2016 Determining Functional Aptamer-Protein Interaction by Biolayer Interferometry. RISC, siRNA
47  2016 Interactions between depolymerized fucosylated glycosaminoglycan and coagulation proteases or inhibitors. AT, dFG, FG, FIIa, FIXa, FXa
48  2016 Isolation of Potent CGRP Neutralizing Antibodies Using Four Simple Assays. CGRP, HTRF
49  2016 Multiple approaches to assess pectin binding to galectin-3. cFLISA, FP, Gal-3, SPR
50  2016 Origin and prediction of free-solution interaction studies performed label-free. BSI, FreeSRF, MS, RI, SPR
51  2016 Protein folding on biosensor tips: folding of maltodextrin glucosidase monitored by its interactions with GroEL. ---
52  2016 Structure of Gremlin-1 and analysis of its interaction with BMP-2. BMP-2, TGF-beta
53  2015 A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life. IgG, mAbs
54  2015 Effect of protein aggregates on characterization of FcRn binding of Fc-fusion therapeutics. ---
55  2015 In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor alpha. AF-2, cdc2, ERalpha, TamR
56  2015 Label-free kinetic analysis of an antibody-antigen interaction using biolayer interferometry. ---
57  2015 Measuring protein-protein and protein-nucleic Acid interactions by biolayer interferometry. ---
58  2015 Milk matrix effects on antibody binding analyzed by enzyme-linked immunosorbent assay and biolayer interferometry. ASF, ELISA, mAb
59  2015 Recognization of receptors on bone marrow-derived dendritic cells bound with Pholiota nameko polysaccharides. BMDCs
60  2014 A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27. OPXV
61  2014 A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1. ---
62  2014 Characterization and screening of IgG binding to the neonatal Fc receptor. CDR, Fab, IgG, SPR, VH, VL
63  2014 Characterizing aptamer small molecule interactions with backscattering interferometry. BSI, SM, SPR
64  2014 High-throughput epitope binning assays on label-free array-based biosensors can yield exquisite epitope discrimination that facilitates the selection of monoclonal antibodies with functional activity. mAbs, SPRi
65  2014 Probing structurally altered and aggregated states of therapeutically relevant proteins using GroEL coupled to bio-layer interferometry. mAb, SEC, TEM
66  2014 Production of anti-idiotype antibodies for deoxynivalenol and their evaluation with three immunoassay platforms. cdELISA, DON, FPIA, mAb
67  2014 Reducing protein adsorption with polymer-grafted hyaluronic acid coatings. AFM, BSA, Fbg, HA, QCM-D
68  2014 Tetraspecific ligand for tumor-targeted delivery of nanomaterials. AuNPs, SPR
69  2014 YlxM is a newly identified accessory protein that influences the function of signal recognition particle pathway components in Streptococcus mutans. ELISA, scRNA, SRP
70  2014 [Expression, purification and hIgG-binding activity identification of truncated Streptococcus suis factor H-binding protein]. Fhb, hIgG
71  2013 Application of Bio-Layer Interferometry for the analysis of protein/liposome interactions. rhEPO, SA
72  2013 High throughput detection of antibody self-interaction by bio-layer interferometry. CIC, CSI, SIC
73  2013 High throughput solution-based measurement of antibody-antigen affinity and epitope binning. MSD, SPR
74  2013 Monitoring the kinetics of the pH-driven transition of the anthrax toxin prepore to the pore by biolayer interferometry and surface plasmon resonance. LF, PA
75  2012 MIRG Survey 2011: snapshot of rapidly evolving label-free technologies used for characterizing molecular interactions. AUC, ITC, MIRG, SPR
76  2012 Practical quantitative and kinetic applications of bio-layer interferometry for toxicokinetic analysis of a monoclonal antibody therapeutic. ADA
77  2012 Signal amplification using colloidal gold in a biolayer interferometry-based immunosensor for the mycotoxin deoxynivalenol. DON
78  2011 Biosensor-based small molecule fragment screening with biolayer interferometry. SPR
79  2011 Soluble periplasmic production of human granulocyte colony-stimulating factor (G-CSF) in Pseudomonas fluorescens. G-CSF
80  2010 Optical biosensing: Kinetics of protein A-IGG binding using biolayer interferometry. SPR
81  2009 Label-free detection of biomolecular interactions using BioLayer interferometry for kinetic characterization. ---